ALNYLAM PHARMACEUT earnings per share and revenue

DUL earnings per share for the last quarter are -0.59 CHF whereas the estimation was -0.54 CHF which accounts for -9.78% surprise. Company revenue for the same period amounts to 538.71 M CHF despite the estimated figure of 529.12 M CHF. Estimated earnings per share for the next quarter are -0.85 CHF, and revenue is expected to reach 533.70 M CHF. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.